EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Data-driven modelling of tau pathology reveals distinct progressive supranuclear palsy subtypes

Patrick W Cullinane iD, Jacy Bezerra Parmera iD, Hemanth Nelvagal iD, Toby Curless, Leckhna Paras Chajed, Sarah Wrigley, Walter Sifontes Valladares, Maggie Burrows, Kirsten Ebanks, Lesley Wu iD, Lawrence P Binding, Jaime Anton und 15 weitere

Brain · 07.09.2026 · 149 (9) · 3080-3094

DOI: 10.1093/brain/awag131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 13.04.2026. Verfasst von Patrick W Cullinane und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive, tau Proteins, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UKRI, MRC, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Progressive supranuclear palsy (PSP) is a heterogeneous neurodegenerative disease characterized by the accumulation of misfolded 4-repeat tau within neurons and glial cells. There are limited longitudinal data on pathologically confirmed PSP patients with phenotypes other than classic Richardson’s syndrome (RS) and the pathomechanisms responsible for the broad variability in clinical phenotype and progression are not well understood. An unresolved question in this context is whether distinct spatiotemporal patterns of tau pathology propagation exist within the clinicopathological spectrum of PSP. We included 241 consecutive, pathologically confirmed patients with PSP from the Queen Square Brain Bank for Neurological Disorders (2010–2022). Phenotyping was performed based on clinical features present within the first 3 years from symptom onset according to the Movement Disorder Society (MDS) criteria, and specific clinical features and disease milestones were recorded. Genotyping was performed using Illumina NeuroBooster and NeuroChip arrays and MAPT haplotype, APOE genotype, TRIM11 rs564309 and SLC2A13 rs2242367 single nucleotide polymorphism data were collated. Tissue sections from eight brain regions, mounted on glass slides, were immunostained for hyperphosphorylated tau and digitized using whole-slide scanning. Forty-one anatomical regions of interest were manually segmented, and total tau pathology burden was quantified using an automated, machine learning-based algorithm. The associations between survival and both clinicogenetic features and regional tau pathology burden were modelled using Cox regression and generalized linear models, respectively, and the Subtype and Stage Inference (SuStaIn) algorithm was used to identify subgroups with distinct progression patterns. We have identified: (i) several clinical predictors of survival in PSP and the relationship between regional tau pathology burden and survival; (ii) novel anatomical reference standards for the expected distribution of tau pathology across MDS-defined PSP phenotypes, including region-specific white matter involvement in patients with corticobasal syndrome and speech/language variants; (iii) associations potentially linking biological sex, MAPT haplotype and TAR DNA-binding protein 43 (TDP-43) co-pathology to clinical phenotype and regional tau pathology burden; (iv) patterns of covariance in regional tau pathology implicating inter-regional connectivity in tau spreading; and (v) three distinct spatiotemporal patterns of tau pathology progression: one characterized by initial involvement of subcortical grey matter followed by rostral spread to cortical regions and two characterized by early, simultaneous involvement of subcortical grey matter and cortical regions. Taken together, these results indicate that PSP clinicopathological heterogeneity is mediated by propagation of tau pathology along anatomically connected networks and via intrinsic regional susceptibility mechanisms, possibly influenced by sex, genetic factors and co-pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Supranuclear Palsy, Progressivetau ProteinsBrainHumansFemaleAgedMaleMiddle AgedDisease ProgressionPhenotypeAged, 80 and overTauopathies

Stichwörter der Autor:innen

disease progression modellingmachine learningphenotypic heterogeneitytauopathy

Substanzen

tau ProteinsMAPT protein, human

Autor:innen und Institutionen

  • Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
  • Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London WC1N 1PJ, UK.
  • Reta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology, London WC1N 1PJ, UK.
  • Queen Square Movement Disorders Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
  • Department of Neurology, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo 05402 000, Brazil.
  • UCL Hawkes Institute, Department of Computer Science, University College London, London WC1V 6LJ, UK.

ORCID-Profile: Patrick W Cullinane, Jacy Bezerra Parmera, Hemanth Nelvagal, Lesley Wu, Raquel Real, David P Vaughan, Edwin Jabbari, Huw R Morris, Sebastian Brandner, Eduardo de Pablo-Fernández, Thomas T Warner

Förderung

  • UKRI
  • MRC
  • Wellcome Trust
  • Parkinson's UK
  • Edmond J. Safra Foundation
  • Reta Lila Weston Trust
  • Parkinson’s UK

Zitieren

APA

Cullinane, P. W., Parmera, J. B., Nelvagal, H., Curless, T., Chajed, L. P., Wrigley, S., Sifontes Valladares, W., Burrows, M., Ebanks, K., Wu, L., Binding, L. P., Anton, J., Revesz, T., Real, R., Vaughan, D. P., Jabbari, E., Morris, H. R., Brandner, S., Young, A. L., …, & Jaunmuktane, Z. (2026). Data-driven modelling of tau pathology reveals distinct progressive supranuclear palsy subtypes. Brain, 149(9), 3080-3094. https://doi.org/10.1093/brain/awag131

Vancouver

Cullinane PW, Parmera JB, Nelvagal H, Curless T, Chajed LP, Wrigley S, et al. Data-driven modelling of tau pathology reveals distinct progressive supranuclear palsy subtypes. Brain. 2026;149(9):3080-3094. doi:10.1093/brain/awag131

BibTeX
@article{Cullinane2026,
  author = {Cullinane, Patrick W and Parmera, Jacy Bezerra and Nelvagal, Hemanth and Curless, Toby and Chajed, Leckhna Paras and Wrigley, Sarah and Sifontes Valladares, Walter and Burrows, Maggie and Ebanks, Kirsten and Wu, Lesley and Binding, Lawrence P and Anton, Jaime and Revesz, Tamas and Real, Raquel and Vaughan, David P and Jabbari, Edwin and Morris, Huw R and Brandner, Sebastian and Young, Alexandra L and Hoti, Glen and Ma, Yangxinrui and Bechtawi, Mariam and Chiraki, Nancy and de Pablo-Fernández, Eduardo and Lim, Yau Mun and Warner, Thomas T and Jaunmuktane, Zane},
  title = {Data-driven modelling of tau pathology reveals distinct progressive supranuclear palsy subtypes},
  journal = {Brain},
  year = {2026},
  volume = {149},
  number = {9},
  pages = {3080--3094},
  doi = {10.1093/brain/awag131}
}
Kostenlos starten →